Report Detail
COVID-19 Impact on Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2020-2026
- RnM4261825 |
- 05 December, 2020 |
- Global |
- 134 Pages |
- QYResearch |
- Medical Industry
Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the industry. The pharmaceutical industry is the most regulated of all industries. Regulatory affairs professionals are key, but perhaps overlooked, players in drug development. They are the primary communications link between the company and agencies such as FDA, and they are responsible for keeping up with the increasing scope and complexity of regulations. In the pharmaceutical industry, regulatory affairs professionals have expertise in the legal and regulatory environments, as well as in clinical research protocols.
Market Analysis and Insights: Global Pharmaceutical Regulatory Affairs Market
The global Pharmaceutical Regulatory Affairs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Regulatory Affairs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Regulatory Affairs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Regulatory Affairs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Regulatory Affairs market.
Pharmaceutical Regulatory Affairs Breakdown Data by Type
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Pharmaceutical Regulatory Affairs Breakdown Data by Application
In-house
Outsourcing
Based on regional and country-level analysis, the Pharmaceutical Regulatory Affairs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Regulatory Affairs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Market Analysis by Type
- 1.3.1 Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type: 2020 VS 2026
- 1.3.2 Regulatory Consulting
- 1.3.3 Legal Representation
- 1.3.4 Regulatory Writing & Publishing
- 1.3.5 Product Registration & Clinical Trial Application
- 1.3.6 Other Services
- 1.4 Market by Application
- 1.4.1 Global Pharmaceutical Regulatory Affairs Market Share by Application: 2020 VS 2026
- 1.4.2 In-house
- 1.4.3 Outsourcing
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pharmaceutical Regulatory Affairs Market Perspective (2015-2026)
- 2.2 Pharmaceutical Regulatory Affairs Growth Trends by Regions
- 2.2.1 Pharmaceutical Regulatory Affairs Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Pharmaceutical Regulatory Affairs Historic Market Share by Regions (2015-2020)
- 2.2.3 Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2021-2026)
- 2.3 Pharmaceutical Regulatory Affairs Industry Dynamic
- 2.3.1 Pharmaceutical Regulatory Affairs Market Trends
- 2.3.2 Pharmaceutical Regulatory Affairs Market Drivers
- 2.3.3 Pharmaceutical Regulatory Affairs Market Challenges
- 2.3.4 Pharmaceutical Regulatory Affairs Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Pharmaceutical Regulatory Affairs Players by Market Size
- 3.1.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue (2015-2020)
- 3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2015-2020)
- 3.2 Global Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Pharmaceutical Regulatory Affairs Revenue
- 3.4 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio
- 3.4.1 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Regulatory Affairs Revenue in 2019
- 3.5 Key Players Pharmaceutical Regulatory Affairs Area Served
- 3.6 Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
- 3.7 Date of Enter into Pharmaceutical Regulatory Affairs Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Regulatory Affairs Breakdown Data by Type
- 4.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Type (2015-2020)
- 4.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2021-2026)
5 Pharmaceutical Regulatory Affairs Breakdown Data by Application
- 5.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Application (2015-2020)
- 5.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Pharmaceutical Regulatory Affairs Market Size (2015-2026)
- 6.2 North America Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
- 6.3 North America Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
- 6.4 North America Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Pharmaceutical Regulatory Affairs Market Size (2015-2026)
- 7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
- 7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
- 7.4 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
8 Asia-Pacific
- 8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size (2015-2026)
- 8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
- 8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
- 8.4 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
9 Latin America
- 9.1 Latin America Pharmaceutical Regulatory Affairs Market Size (2015-2026)
- 9.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
- 9.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
- 9.4 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size (2015-2026)
- 10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
- 10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
- 10.4 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
11Key Players Profiles
- 11.1 QuintilesIMS
- 11.1.1 QuintilesIMS Company Details
- 11.1.2 QuintilesIMS Business Overview
- 11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Introduction
- 11.1.4 QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020))
- 11.1.5 QuintilesIMS Recent Development
- 11.2 LabCor
- 11.2.1 LabCor Company Details
- 11.2.2 LabCor Business Overview
- 11.2.3 LabCor Pharmaceutical Regulatory Affairs Introduction
- 11.2.4 LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.2.5 LabCor Recent Development
- 11.3 PAREXEL
- 11.3.1 PAREXEL Company Details
- 11.3.2 PAREXEL Business Overview
- 11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Introduction
- 11.3.4 PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.3.5 PAREXEL Recent Development
- 11.4 Pharmaceutical Product Development
- 11.4.1 Pharmaceutical Product Development Company Details
- 11.4.2 Pharmaceutical Product Development Business Overview
- 11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Introduction
- 11.4.4 Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.4.5 Pharmaceutical Product Development Recent Development
- 11.5 INC RESEARCH HOLDINGS
- 11.5.1 INC RESEARCH HOLDINGS Company Details
- 11.5.2 INC RESEARCH HOLDINGS Business Overview
- 11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Introduction
- 11.5.4 INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.5.5 INC RESEARCH HOLDINGS Recent Development
- 11.6 PRA Health Sciences
- 11.6.1 PRA Health Sciences Company Details
- 11.6.2 PRA Health Sciences Business Overview
- 11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Introduction
- 11.6.4 PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.6.5 PRA Health Sciences Recent Development
- 11.7 ICON
- 11.7.1 ICON Company Details
- 11.7.2 ICON Business Overview
- 11.7.3 ICON Pharmaceutical Regulatory Affairs Introduction
- 11.7.4 ICON Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.7.5 ICON Recent Development
- 11.8 Charles River
- 11.8.1 Charles River Company Details
- 11.8.2 Charles River Business Overview
- 11.8.3 Charles River Pharmaceutical Regulatory Affairs Introduction
- 11.8.4 Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.8.5 Charles River Recent Development
- 11.9 Advent International
- 11.9.1 Advent International Company Details
- 11.9.2 Advent International Business Overview
- 11.9.3 Advent International Pharmaceutical Regulatory Affairs Introduction
- 11.9.4 Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.9.5 Advent International Recent Development
- 11.10 WuXi AppTec, Inc.
- 11.10.1 WuXi AppTec, Inc. Company Details
- 11.10.2 WuXi AppTec, Inc. Business Overview
- 11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Introduction
- 11.10.4 WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 11.10.5 WuXi AppTec, Inc. Recent Development
- 11.11 Pharmaron Beijing Co., Ltd.
- 10.11.1 Pharmaron Beijing Co., Ltd. Company Details
- 10.11.2 Pharmaron Beijing Co., Ltd. Business Overview
- 10.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Introduction
- 10.11.4 Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.11.5 Pharmaron Beijing Co., Ltd. Recent Development
- 11.12 Hangzhou Tigermed Consulting Co.,Ltd.
- 10.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Details
- 10.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
- 10.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
- 10.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
- 11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
- 10.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
- 10.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
- 10.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
- 10.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
- 11.14 Accell Clinical Research, LLC.
- 10.14.1 Accell Clinical Research, LLC. Company Details
- 10.14.2 Accell Clinical Research, LLC. Business Overview
- 10.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Introduction
- 10.14.4 Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.14.5 Accell Clinical Research, LLC. Recent Development
- 11.15 GenPact Ltd.
- 10.15.1 GenPact Ltd. Company Details
- 10.15.2 GenPact Ltd. Business Overview
- 10.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Introduction
- 10.15.4 GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.15.5 GenPact Ltd. Recent Development
- 11.16 Criterium, Inc.
- 10.16.1 Criterium, Inc. Company Details
- 10.16.2 Criterium, Inc. Business Overview
- 10.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Introduction
- 10.16.4 Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.16.5 Criterium, Inc. Recent Development
- 11.17 Promedica International
- 10.17.1 Promedica International Company Details
- 10.17.2 Promedica International Business Overview
- 10.17.3 Promedica International Pharmaceutical Regulatory Affairs Introduction
- 10.17.4 Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.17.5 Promedica International Recent Development
- 11.18 Medpace
- 10.18.1 Medpace Company Details
- 10.18.2 Medpace Business Overview
- 10.18.3 Medpace Pharmaceutical Regulatory Affairs Introduction
- 10.18.4 Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.18.5 Medpace Recent Development
- 11.19 Covance
- 10.19.1 Covance Company Details
- 10.19.2 Covance Business Overview
- 10.19.3 Covance Pharmaceutical Regulatory Affairs Introduction
- 10.19.4 Covance Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.19.5 Covance Recent Development
- 11.20 Freyr
- 10.20.1 Freyr Company Details
- 10.20.2 Freyr Business Overview
- 10.20.3 Freyr Pharmaceutical Regulatory Affairs Introduction
- 10.20.4 Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
- 10.20.5 Freyr Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Pharmaceutical Regulatory Affairs. Industry analysis & Market Report on COVID-19 Impact on Global Pharmaceutical Regulatory Affairs is a syndicated market report, published as COVID-19 Impact on Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pharmaceutical Regulatory Affairs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
